Silvant Capital Management’s Celgene Corp CELG Stock Holding History

Silvant Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-676	Closed	-$67K	–	347
2019 Q3	$67K	Sell	676 -148	-18%	-$14.1K	0.01%	246
2019 Q2	$76K	Hold	824	–	–	0.01%	252
2019 Q1	$78K	Hold	824	–	–	0.01%	245
2018 Q4	$53K	Hold	824	–	–	0.01%	272
2018 Q3	$74K	Hold	824	–	–	0.01%	265
2018 Q2	$65K	Hold	824	–	–	0.01%	269
2018 Q1	$74K	Buy	+824	New	+$79.1K	0.01%	268

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Silvant Capital Management's CELG Position: Q4 2019 in Review

Silvant Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 676 shares — an estimated $67K sold.

Silvant Capital Management first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $78K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Silvant Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Silvant Capital Management sold 676 Celgene Corp shares in Q4 2019, an estimated $67K.
Silvant Capital Management first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
Silvant Capital Management's Celgene Corp position peaked at $78K in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Silvant Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.